Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways  by Alarcón, Claudio et al.
Nuclear CDKs Drive Smad
Transcriptional Activation and Turnover
in BMP and TGF-b Pathways
Claudio Alarco´n,1,7 Alexia-Ileana Zaromytidou,1,6 Qiaoran Xi,1,6 Sheng Gao,1,6,8 Jianzhong Yu,4 Sho Fujisawa,2
Afsar Barlas,2 Alexandria N. Miller,1 Katia Manova-Todorova,2 Maria J. Macias,3 Gopal Sapkota,1,9 Duojia Pan,4,5
and Joan Massague´1,5,*
1Cancer Biology and Genetics Program
2Molecular Cytology Core Facility
Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
3Structural and Computational Biology Programme, Institute for Research in Biomedicine, Barcelona 08028, Spain
4Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
5Howard Hughes Medical Institute
6These authors contributed equally to this work
7Present address: The Rockefeller University, 1230 York Avenue, New York, NY 10065-6399, USA
8Present address: Merck & Co. Inc., 126 E. Lincoln Avenue, Rahway, NJ 07065, USA
9Present address: MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK
*Correspondence: massaguj@mskcc.org
DOI 10.1016/j.cell.2009.09.035SUMMARY
TGF-b and BMP receptor kinases activate Smad
transcription factors by C-terminal phosphorylation.
We have identified a subsequent agonist-induced
phosphorylation that plays a central dual role in
Smad transcriptional activation and turnover. As
receptor-activated Smads form transcriptional com-
plexes, they are phosphorylated at an interdomain
linker region by CDK8 and CDK9, which are compo-
nents of transcriptional mediator and elongation
complexes. These phosphorylations promote Smad
transcriptional action, which in the case of Smad1
is mediated by the recruitment of YAP to the phos-
phorylated linker sites. An effector of the highly
conserved Hippo organ size control pathway, YAP
supports Smad1-dependent transcription and is
required for BMP suppression of neural differentia-
tion of mouse embryonic stem cells. The phosphory-
lated linker is ultimately recognized by specific
ubiquitin ligases, leading to proteasome-mediated
turnover of activated Smad proteins. Thus, nuclear
CDK8/9 drive a cycle of Smad utilization and disposal
that is an integral part of canonical BMP and TGF-b
pathways.
INTRODUCTION
The transforming growth factor b (TGF-b) family of cytokines are
key regulators of metazoan embryo development and adult
tissue homeostasis. In the canonical pathway, ligands of boththe TGF-b and the BMP (bone morphogenetic protein) branches
of this family bind to heteromeric serine/threonine kinase
receptor complexes, which in turn phosphorylate Smad tran-
scription factors at their C-terminal tails. This phosphorylation
induces Smads 1, 5, and 8 in the BMP pathway and Smads 2
and 3 in the TGF-b pathway to accumulate in the nucleus and
assemble transcriptional complexes that regulate hundreds of
target genes (Feng and Derynck, 2005; Massague´, 1998).
The TGF-b and BMP pathways are intensely regulated by
inputs that adjust pathway activity according to contextual
status. Antagonists such as fibroblast growth factor (FGF) and
epidermal growth factor (EGF) and cell stress signals act through
mitogen-activated protein kinases (MAPKs) to cause phosphor-
ylation of a region that links the DNA-binding and transcriptional
domains of the Smads (Aubin et al., 2004; Grimm and Gurdon,
2002; Kretzschmar et al., 1997; Pera et al., 2003). The Smad
linker is also phosphorylated by G1 cyclin-dependent kinases
during the cell cycle (Matsuura et al., 2004) and by GSK3b com-
plementing MAPK action (Fuentealba et al., 2007; Sapkota et al.,
2007). Linker phosphorylation of Smads in the basal state leads
to their cytoplasmic retention and ubiquitin ligase-driven, protea-
somal degradation (Gao et al., 2009; Sapkota et al., 2007), with
an attendant decrease in the responsiveness of cells to BMP
and TGF-b signals (Grimm and Gurdon, 2002; Kretzschmar
et al., 1997, 1999; Pera et al., 2003).
Smad linker phosphorylation by antagonists provides a critical
counterbalance to TGF-b and BMP signaling. This has led to
postulates that in the canonical pathways C-tail phosphorylation
activates Smad signaling and linker phosphorylation inhibits it
(Fuentealba et al., 2007; Sapkota et al., 2007). However, this
dichotomy is not so tidy. Our present investigation of the BMP-
induced Smad1 linker phosphorylation that we had reported
previously (Sapkota et al., 2007) reveals unexpected facets
of the canonical TGF-b and BMP pathways. Unlike linkerCell 139, 757–769, November 13, 2009 ª2009 Elsevier Inc. 757
phosphorylation by antagonistic signals, which is cytoplasmic
and MAPK mediated, agonist-induced linker phosphorylation
(abbreviated from here on as ALP) occurs during or directly prior
to the assembly of Smad proteins into transcriptional complexes
and is mediated by CDK8 and CDK9. CDK8 is part of Mediator,
a multisubunit complex that couples transcription factors to RNA
polymerase II (RNAP II) (Malik and Roeder, 2000). CDK8 phos-
phorylates the C-terminal domain (CTD) of RNAP II and certain
enhancer-binding transcription factors (Donner et al., 2007; Fire-
stein et al., 2008; Morris et al., 2008). CDK9 phosphorylates the
RNAP II CTD at distinct sites to enhance transcriptional elonga-
tion (Durand et al., 2005; Komarnitsky et al., 2000).
The present work further reveals that the CDK8/9-mediated
Smad ALP results in full activation of Smad-dependent tran-
scription, while at the same time priming Smad proteins for
eventual degradation. We show that ALP activation of Smad1
involves YAP (Yes-associated protein, also known as YAP1 or
YAP65), the end target of the Hippo pathway (Huang et al.,
2005), which mediates cell-contact growth inhibition, organ
size control, and tumor suppression (Dong et al., 2007; Overholt-
zer et al., 2006; Zhao et al., 2007). Thus the present findings
reveal a dual role for ALP and shed light on previously unrecog-
nized events of the canonical BMP and TGF-b pathways.
RESULTS
Agonist-Induced Smad Linker Phosphorylation
Phosphorylation of the Smad1 linker region is induced not only
by antagonists acting through MAPKs but also by the pathway
agonist BMP2 (Sapkota et al., 2007). To determine the generality
of Smad ALP, BMP2 or TGF-b1 treated HaCaT cell extracts were
probed with Smad phosphopeptide antibodies against phos-
pho-Ser206 (pS206) in Smad1 (Sapkota et al., 2007), which
does not appear to cross-react with Smad5 (data not shown),
and phospho-Thr220/179 (pT220/179) in Smad2/3 (Gao et al.,
2009) (refer to Figure S1 available online). BMP induced the
phosphorylation of the Smad1 linker region and C-tail of
Smad1/5, and TGF-b did the same to Smads 2 and 3 (Figure 1A).
Cell fractionation (Figure 1A) and immunofluorescence staining
(Figures 1B and 1C) showed that linker-phosphorylated Smads
accumulate in the nucleus. ALP occurred 10 min after
receptor-mediated tail phosphorylation (Figure 1D).
In embryonic day (E) 13.5 mouse embryos, the immunostain-
ing pattern of both linker-phosphorylated Smad1 and tail-phos-
phorylated Smad1/5 was mostly nuclear (Figures 1E, S2A, and
S2B) and showed a high degree of colocalization (Figures 1F
and S2B). Phospholinker Smad1 and phosphotail Smad1/5
were detected in the ventricular zones of the brain ventricles
(Figure 1E), in tooth buds (Figure S2A), and in the spinal cord
canal and dorsal root ganglia (data not shown). Moderate levels
were seen in the gastric wall (Figure S2A), in developing heart
valves, and in epithelial cells of lung bronchioles and kidney
tubules (data not shown). Phospholinker and phosphotail
Smad2 staining overlapped in nuclei of dorsal root ganglia (Fig-
ures 1G and 1H), and only partially colocalized in male germ cells
(Figure 1I), and in brain and spinal cord ventricular zones (data
not shown). Phosphotail Smad2 with little or no phospholinker
staining was observed in tooth buds, mesenchymal cells758 Cell 139, 757–769, November 13, 2009 ª2009 Elsevier Inc.surrounding large airways (Figures S2C and S2D), and in heart
valves, the aortic wall, and vertebral ossification centers (data
not shown). In sum, Smad linker phosphorylation accompanying
C-tail phosphorylation is a general feature of the BMP and TGF-b
pathways.
ALP Occurs during Transcriptional Complex Assembly
To determine the requirements for ALP we used mouse embry-
onic fibroblasts (MEFs) derived from wild-type (WT) embryos
and embryos homozygous for knocked-in Smad1 alleles with
alanine mutations of C-tail (Smad1C) or linker (Smad1L) phos-
phorylation sites (Aubin et al., 2004). BMP failed to induce ALP
of Smad1C, despite the presence in this mutant of intact linker
sites, in contrast to UV cell irradiation (Figure 2A), which induces
cytoplasmic Smad1 linker phosphorylation through JNK and p38
MAPKs (Sapkota et al., 2007). This suggested that Smad1 C-tail
phosphorylation is not required for linker phosphorylation by
antagonistic MAPKs but is essential in vivo for linker phosphor-
ylation by agonist-dependent kinases.
Smad ALP was observed in all cell lines tested except in cells
lacking Smad4, a general partner of receptor-activated Smads
(R-Smads), which binds to their phosphorylated C-tail and
nucleates transcriptional complexes (Massague´ et al., 2005). In
the Smad4-defective human colon cancer line SW480 and
pancreatic cancer line BxPC3, BMP induced tail phosphoryla-
tion and nuclear accumulation of Smad1/5 but only minimal
Smad1 linker phosphorylation (Figures 2B and S3). Similar
results were obtained with Smad3 in response to TGF-b (Fig-
ure 2C). Restoration of Smad4 expression rescued the ability
of Smad1 and Smad3 to undergo ALP (Figures 2B, 2C, and
S3). These results suggested that Smads undergo ALP as a result
of phosphotail-driven incorporation into Smad4-containing tran-
scriptional complexes.
To determine whether the ALP-Smads are present on the
regulatory regions of target genes, we performed chromatin
immunoprecipitation (ChIP) assays. In BMP-treated cells, but
not in controls, both an anti-Smad1/5 antibody and an antibody
against phospho-Ser206 of Smad1 pulled down DNA that
included the BMP-responsive regions of Inhibitor of DNA binding
1 (Id1) and Smad7 (Figure 2D). Similarly, in TGF-b-treated cells,
an antibody against the linker phosphorylated Smad3 and an
anti-Smad2/3 antibody pulled down DNA containing the TGF-b
responsive element of theSmad7 gene (Figure 2D). Treating cells
with the RNAP II inhibitor a-amanitin did not affect Smad1 ALP
(Figure 2E), indicating that this event accompanies, but is not
a consequence of, active transcription.
ALP Primes Smads for Turnover
Linker-phosphorylated Smad1 is recognized by Smurf1 (Sap-
kota et al., 2007) and linker-phosphorylated Smad2/3 by Nedd4L
(Gao et al., 2009), both of which belong to the HECT family of E3
ubiquitin ligases. Members of this family bind their substrates via
WW domains that interact with PPXY sequences (PY motifs),
normally without requiring supporting contacts with phosphory-
lated sites (Ingham et al., 2004). However, the PY motifs in the
linker regions of Smads 1, 2, and 3 are not sufficient for produc-
tive interactions with Smurf1 or Nedd4L. Smurf1 binding requires
phosphorylation of at least one serine residue in a SerPro cluster
Figure 1. TGF-b and BMP Induce Smad C-Tail and Linker Phosphorylation
(A) Nuclear and cytoplasmic fractions of BMP- or TGF-b-treated (1 hr) HaCaT cells were analyzed by western blot with the indicated antibodies.
(B and C) HaCaT cells treated with BMP, TGF-b, or no addition (control) for 1 hr were fixed and analyzed by immunofluorescence (IF) with antibodies against
Smad1 (pLinker, Smad1 pS206; pTail, Smad1/5 pTail) and Smad3 (pLinker, Smad3 pS213; pTail, Smad3 pTail) including DAPI staining of nuclei.
(D) As in (B), with BMP treatment for the indicated times.
(E–I) Images of E13.5 mouse embryo sections. (E) Adjacent sections through the telencephalic ventricular zone immunohistochemically stained with anti-Smad1
antibodies described in (B) and (C), with Hematoxylin counterstaining. Images at 403magnification. Ventricle and ventricular zone (VZ) are indicated. (F) Confocal
images of a section similar to (A) with double-immunofluorescence staining using the indicated antibodies and DAPI counterstaining. Images are at 203magni-
fication, with the far right panel at 2003. The ventricular zone is indicated by white dashed lines. (G) Immunohistochemistry on adjacent sections through dorsal
root ganglia stained as in (E), with antibodies against Smad2 (pLinker Smad2, Smad2 pS245/250/245; pTail Smad2). Images at 803magnification. (H) Confocal
images of dorsal root ganglia with double-immunofluorescence staining with the antibodies used in (G). Magnification was 803. (I) Merged confocal image of
E13.5 testis from the same section as in (H).of the Smad1 linker region, preferably S206 and S214 (Sapkota
et al., 2007). Nedd4L binding to Smads 2 and 3 requires phos-
phorylation of a Thr residue (T220 in Smad2, T179 in Smad3)
located immediately upstream of the PY motif (Gao et al.,
2009). Since ALP prominently targeted these residues (Figures
1A and S1), we postulated that Smurf1 and Nedd4L mediate pro-
teasome degradation of activated Smad proteins.
Cells were treated with BMP or TGF-b for 1 hr to achieve peak
Smad tail phosphorylation, followed by removal of agonist to
determine the decay of tail-phosphorylated Smads. Depletion
of Smurf1 by RNAi delayed the decay of activated Smad1/5 as
effectively as addition of a proteasome inhibitor MG132 (Fig-ure 2F), and the same was seen for activated Smad2/3 after
Nedd4L depletion (Figure 2G). RNAi-mediated depletion of
FoxO4, which is ubiquitously coexpressed and functionally
redundant with FoxO1 and FoxO3 (Gomis et al., 2006), was
used as a negative control.
Proteasome inhibition with MG132 led to accumulation of tail-
phosphorylated Smad1/5 and linker-phosphorylated Smad1
both in the nucleus and in the cytoplasm (Figure S4). MG132
did not fully block the decay of tail-phosphorylated Smads,
consistent with the participation of Smad C-terminal phospha-
tases as an alternative mechanism for Smad deactivation (Inman
et al., 2002; Knockaert et al., 2006; Lin et al., 2006). FurthermoreCell 139, 757–769, November 13, 2009 ª2009 Elsevier Inc. 759
Figure 2. Requirements for Smad ALP
(A) Immunoblot analysis of wild-type, Smad1C, and Smad1L mutant knockin MEFs treated with BMP or UV, with antibodies against the indicated proteins.
(B and C) SW480 Smad4 null cells or cells stably expressing Smad4 were treated with BMP (B) or TGF-b (C). Nuclear and cytoplasmic fractions were analyzed
using the indicated antibodies.
(D) Chromatin immunoprecipitation of BMP- and TGF-b-stimulated C2C12 cells with the indicated antibodies. Precipitates were subjected to qRT-PCR of the
BMP- and TGF-b-responsive regions of the indicated genes with unresponsive regions of the same genes serving as negative controls. Data show the
mean ± standard deviation (SD) of triplicates and are representaive of at least two independent expreriments.
(E) Immunoblot analysis of BMP-treated HaCaT cells in the absence or after addition of a-amanitin for the indicated times. Total cell extracts were analyzed using
the indicated antibodies.
(F) HaCaT cells were stimulated with BMP for 1 hr in the absence or presence of MG132 or of a siRNA against Smurf1. Cells were harvested at the indicated times
after BMP removal and total cell extracts were analyzed by immunoblot.
(G) As in (F) but cells were stimulated with TGF-b and siRNA against Nedd4L was used.
(H) Schematic model of the sequential steps leading to Smad-ALP and binding of ubiquitin ligases.the CRM1 inhibitor leptomycin B, which had been previously re-
ported to block Smad1 nuclear export (Xiao et al., 2001), resulted
in increased levels of tail-phosphorylated Smad1/5 and linker-
phosphorylated Smad1 (Figure S4). Taken together these results
indicate that ALP is a consequence of Smad assembly into tran-
scriptional complexes in the nucleus, occurs during or just prior
to Smad binding to chromatin, and targets Smads to specific
ubiquitin ligases for proteosomal turnover (Figure 2H).
CDK8 and CDK9 Mediate Smad ALP
BMP-induced Smad1 linker phosphorylation was not sup-
pressed by inhibitors of MEK (U0126), p38 (SB203580), or JNK
(SP600125) tested individually, in double combination, or in triple760 Cell 139, 757–769, November 13, 2009 ª2009 Elsevier Inc.combination (Figure 3A; data not shown). Of all the protein kinase
inhibitors screened, only the semisynthetic flavonoid flavopiridol
(Shapiro, 2004) effectively inhibited Smad ALP (Figures 3A and
S5), by preventing ALP of nuclear Smad1 in BMP-treated cells
(Figure 3B) and of nuclear Smad3 in TGF-b-treated cells (Fig-
ure 3C). This was accompanied by an increase in the level of
tail-phosphorylated Smad1 and Smad3 (Figures 3B and 3C).
Indeed, flavopiridol extended the half-life of BMP-activated
Smad1/5 as much as MG132 (Figure 3D), and a similar effect
was observed with TGF-b-activated Smad3 (data not shown).
Reducing the list of flavopiridol-sensitive kinases (Fabian et al.,
2005) by using inhibitors of partially overlapping specificity (Fig-
ure S5) led us to cyclin-dependent kinases (CDKs) as potential
Smad-ALP mediators. Various inhibitors of CDKs that function in
the cell cycle did not inhibit BMP-induced Smad1 linker phos-
phorylation. These included roscovitine, purvalanol A, and
UCN01 (Figure S5), which inhibit CDKs 1, 2, 4, 5, and 6 (McClue
et al., 2002; Omura-Minamisawa et al., 2000). The inducible
overexpression of p27Kip1 or p15Ink4b, which inhibit CDKs 2,
4, and 6 and their phosphorylation of the retinoblastoma protein
pRb (Reynisdottir and Massague´, 1997) (Figure S6A), as well as
Figure 3. Flavopiridol Inhibits Smad ALP
(A) Cell extracts of BMP-treated HaCaT cells with or without kinase inhibitors
were analyzed with antibodies against the indicated proteins. SB, SB203580;
SP, SP60125; combo, combination of the three MAPK inhibitors; Flavopir., Fla-
vopiridol.
(B and C) Nuclear and cytoplasmic fractions of HaCaT cells stimulated with
BMP or TGF-b in the absence or presence of Flavopiridol were analyzed by
immunoblotting.
(D) HaCaT cells were stimulated with BMP for 1 hr in the absence or presence
of Flavopiridol (FP) or of Flavopiridol plus MG132. Incubations were continued
for the indicated periods with media without BMP.RNAi-mediated knockdown of CDK1, CDK2, CDK4, or CDK5
(Figures S6B–S6D), also had no effect. These results left as
candidates the transcription-regulatory CDKs 7, 8, and 9.
RNAi-mediated knockdown of CDK8 or CDK9 inhibited the
BMP-induced phosphorylation of S206 in Smad1 and the TGF-
b-induced phosphorylation of T179 in Smad3 (Figures 4A and
4B). RNAi inhibition of both CDK8 and CDK9 resulted in greater
reduction of Smad1-ALP (Figure S6F), suggesting that these
kinases act redundantly, whereas knockdown of CDK7 inhibited
the ALP of S206 in Smad1 but not that of T179 in Smad3 (Figures
4A and 4B). Knockdown of one CDK did not affect the levels of
the others (Figure S6E).
In vitro, recombinant cyclinC-CDK8 and cyclinT1-CDK9 phos-
phorylated Smads 1, 2, and 3 but induced much reduced phos-
phorylation of Smad proteins with mutated linker sites (Figures
4C–4E; see Supplemental Experimental Procedures for descrip-
tion of the Smad linker mutants). Using as substrates Smad1 and
Smad3 proteins with valine or alanine mutations in all but one of
the four Ser/Thr residues of interest, cyclinC-CDK8 and cyclinT-
CDK9 showed a preference for S206 and S214 but also phos-
phorylated S186 and S195 in the case of Smad1 and T179,
S208, and S213 in the case of Smad3. In contrast, ERK2 phos-
phorylated all four Smad1 residues almost evenly, while showing
a preference for S204 over S208 and S213 in Smad3 (Figure 4D).
Activated, tail-phosphorylated Smad1 could be coimmunopreci-
pitated with endogenous CDK8 (Figure 4F) and endogenous
CDK8 with stably expressed Flag-tagged Smad1 in response
to BMP (Figure 4G). CyclinH-CDK7 did not phosphorylate
Smads in vitro, even though it was active at phosphorylating
RNAP II CTD (Figure 4C and data not shown) and thus does
not appear to be a direct Smad linker kinase. Collectively these
results identified CDK8 and CDK9 as mediators of agonist-
dependent linker phosphorylation of Smads (Figure 4H).
Dual Role of CDK8/9 and Linker Phosphorylation
in Smad Function and Turnover
Since Smad phosphorylation by CDK8 and CDK9 creates ubiq-
uitin ligase-binding sites, we asked whether interfering with
CDK8/9 function would stabilize the pool of activated, C-tail
phosphorylated Smads. CDK8- or CDK9-depleted cells were
treated with BMP for 1 hr, followed by incubation without the
agonist to track the decay of tail-phosphorylated Smad1.
CDK8 or CDK9 knockdown delayed the decay of activated
Smad1 (Figure 5A) and Smad3 (data not shown), thus mimicking
the effects of flavopiridol addition (refer to Figures 3B–3D) and of
Smad ubiqutin ligase depletion (refer to Figure 2F).
To assess the effect of ALP on the transcriptional function of
Smad proteins, we compared cells expressing wild-type or
mutant Smad lacking the linker phosphorylation sites. Knocking
down CDK8 and CDK9 was ruled out because the effects of
these protein kinases on general transcription would confound
our results. We generated HaCaT cell lines in which endogenous
Smad1 has been depleted and which stably overexpress either
wild-type Smad1 or the mutant Smad1(mut) with alanines re-
placing all four serines in the linker SerPro cluster. Additional
Smurf1 depletion increased the BMP-dependent accumulation
of tail-phosphorylated Smad1/5 in these cells (Figure 5B). This
effect was accompanied by a stronger induction of the typicalCell 139, 757–769, November 13, 2009 ª2009 Elsevier Inc. 761
Figure 4. CDK8 and CDK9 as Mediators of Smad ALP
(A and B) HaCaT cells were transfected with siRNAs against CDK7, CDK8, or CDK9 or against FoxO4 as a negative control. Total extracts from cells stimulated
with BMP or TGF-b for 1 hr were analyzed by immunoblot.
(C) Autoradiograph of bacterially expressed Smad1 wild-type or linker mutant, phosphorylated in vitro by the indicated CDK/cyclin complexes with g32P-ATP as
substrate. Purified CTD domain of RNA Pol II was used as a positive control for CDK activity.
(D) In vitro kinase assay of the indicated CDK9/cyclinT or CDK8/cyclinC complexes or ERK on bacterially expressed Smad1 and Smad3 wild-type or linker
mutant. The numbers indicate the residue that was left as Ser/Thr in the linker region.
(E) As in (C) but with Smad2 and Smad3 wild-type or linker mutants.
(F) Coimmunoprecipitation of endogenous Smad1/5 and CDK8. Cell extracts from untreated or BMP-treated HaCaT cells were immunoprecipitated using an anti-
CDK8 antibody and analyzed by western immunoblotting with antibodies against Smad1/5 pTail or CDK8 as a loading control.
(G) Flag immunoprecipitates of BMP-treated HaCaT cells stably expressing Flag-Smad1 were analyzed using antibodies against CDK8 or Flag as a loading
control.
(H) Schematic summary of CDK8/9 phosphorylation sites in Smad linker regions and their relationship to ubiquitin ligase recognition sites (Gao et al., 2009; Sap-
kota et al., 2007). Red dots, principal phosphorylation sites; green boxes, PY motifs.BMP/Smad1 target gene ID1 (Figure 5C). The absence of linker
phosphorylation sites led to a constitutive increase in BMP-
dependent accumulation of tail-phosphorylated Smad1(mut),
and this increase was not expanded by Smurf1 depletion
(Figure 5B). This result was consistent with a role of ALP in
Smurf1-dependent turnover of activated Smad1. Surprisingly,
the ID1 response in Smad1(mut) cells was weaker than in
Smad1 cells (Figure 5C), suggesting that lack of ALP makes
Smad1 not only resistant to Smurf1-dependent turnover but
also inefficient as a mediator of transcriptional responses.
A similar pattern was observed with HeLa-S3 cells expressing
Smad3 or a linker phosphorylation site mutant Smad3(mut),
while retaining endogenous Smad3 expression. Nedd4L deple-
tion strongly increased the TGF-b-dependent accumulation of
activated Smad3 (Figure 5D) and the expression of the typical
TGF-b target genes CTGF (connective tissue growth factor)762 Cell 139, 757–769, November 13, 2009 ª2009 Elsevier Inc.and SKIL (SKI-like, also known as SnoN) (Figure 5E). Tail-phos-
phorylated Smad3(mut) accumulated to high levels in response
to TGF-b (Figure 5D), but although the presence of endogenous
Smad3 supported target gene induction, Nedd4L depletion
failed to significantly increase these responses (Figure 5E).
These results suggest that ALP promotes Smad transcriptional
function while marking Smads for turnover (Figure 5F).
Smad1 ALP Recruits YAP
We hypothesized that this dual role of Smad ALP might be based
on the recruitment of different partners at different stages of the
signal transduction cycle. In light of the highly selective interac-
tion between linker-phosphorylated Smads and different ubiqui-
tin ligases, we further postulated that the Smad transcriptional
function depends on the recruitment to the same phosphory-
lated sites of transcription cofactors containing WW domains
Figure 5. Role of CDK8/9 and Linker Phosphorylation in Smad Turnover
(A) Time course of Smad1/5 C-tail phosphorylation after 1 hr of BMP stimulation as in Figure 2F. HaCaT cells transfected with siRNA against CDK8, CDK9, or the
control FoxO4 were stimulated 48 hr later and total lysates were analyzed by immunoblotting. The fourth panel shows a quantitation of the Smad1/5 pTail bands.
(B) HaCaT cells with stable shRNA Smad1 knockdown and stably transduced with vectors encoding Smad1 wild-type or linker mutant were treated with BMP in
the presence of Smurf1 or control siRNA and analyzed by immunoblotting.
(C) The cell lines described in (B) were treated with BMP for 1 hr and cells were harvested 2 hr after BMP removal to test the expression of ID1 by qRT-PCR. Data
show the mean ± SD of quadruplicates and are representative of two independent experiments.
(D) HeLa-S3 cells stably expressing Flag-tagged Smad3 (wild-type or linker mutant) were retrovirally infected with vectors encoding control shRNA or shRNA
against Nedd4L. After treating cells with or without TGF-b for 3 hr, whole-cell lysates were subjected to anti-Flag immunoprecipitation and analyzed by immu-
noblotting.
(E) The cell lines used in (D) were treated with TGF-b for 3 hr, and total RNA was isolated for qRT-PCR analysis ofCTGF orSKIL levels. Values are normalized to the
untreated levels and shown as the fold induction by TGF-b in each cell line. Data are the mean ± SD of quadruplicates and are representative of two independent
experiments.
(F) Schematic representation of the dual role of linker phopshorylation.similar to those of the corresponding Smad ubiquitin ligase.
Focusing on Smad1 we conducted a genome-wide blastp
search for proteins that contain Smurf1-like WW domains but
are not ubiquitin ligases. The top-scoring hit was YAP (Fig-
ure 6A), a transcriptional coactivator that binds PY motifs of
target proteins (Edgar, 2006; Pan, 2007; Zeng and Hong, 2008).
Endogenous YAP and Smad1/5 in HaCaT cells could be coim-
munoprecipitated in a BMP-dependent manner (Figure 6B).Using epitope-tagged Smad expression vectors showed that
YAP binding to Smad1 requires the phosphorylation sites of
the SerPro cluster (Figure 6C), but not T222, the residue directly
adjacent to the PY motif (Figure S7). Moreover, flavopiridol abol-
ished the BMP-induced interaction between endogenous
Smad1 and epitope-tagged YAP or Smurf1 (Figure 6D), confirm-
ing the importance of Smad1-ALP for YAP and Smurf binding.
Isothermal titration calorimetry experiments with a recombinantCell 139, 757–769, November 13, 2009 ª2009 Elsevier Inc. 763
Figure 6. Smad1 Linker Phosphorylation Mediates Binding of YAP
(A) Schematic representation of Smurf1 and YAP. Orange boxes, WW domains; C2, calcium- and lipid-binding domain; HECT, ubiquitin ligase domain; TB, TEAD-
binding domain, TX’N, transcription activation domain.
(B) Coimmunoprecipitation of endogenous YAP and Smad1 in BMP-treated HaCaT cells. Complexes were analyzed by immunoblotting.
(C) HEK293T cells transfected with vectors encoding Flag-tagged Smad1 or Smad3 (wild-type or linker mutant) were subjected to Flag immunoprecipitation and
analyzed by immunoblotting.
(D) HEK293T cells were transfected with vectors encoding HA-tagged YAP or Smurf1 and after BMP stimulation in the presence or absence of flavopiridol, HA
immunoprecipitates were analyzed by immunoblotting using the indicated anti-Smad1 antibodies.
(E) Dissociation constants of the interaction of a YAP (WW1+WW2) protein fragment with the indicated Smad1 linker peptides, as measured by isothermal titration
calorimetry.
(F) Drosophila S2 cells were transfected with Flag-Mad wild-type or linker mutant and Flag-immunoprecipitates were tested for the presence of endogenous
Yorkie by immunoblot.
(G) As in (E), with cotransfection of HA-Yorkie and immunoprecipitation of the HA-species.
(H) As in (F), with transfection and immunoprecipitation of wild-type or WW domain mutant Yorkie.
(I) Schematic representation of the recruitment of YAP upon CDK8/9-mediated linker phosphorylation of Smad1.104 amino acid polypeptide that includes the two YAP WW
domains, and three Smad1 peptides, also showed that the
YAP WW construct had low affinity for a Smad1 peptide contain-
ing only the PY motif (Figure 6E). This interaction was increased
by 2.5-fold by extending the Smad1 peptide to include the two
principal CDK8/9 sites, S206 and S214, and was further
increased by 2.2-fold when these sites were phosphorylated.
An interaction was observed between YAP and Flag-tagged
Smad3 in transfected cells, but this was weak and independent
of Smad3 linker phosphorylation (Figure 6C).
To investigate the conservation of the Smad1-YAP interaction
through species, we tested the ability of their Drosophila ortho-764 Cell 139, 757–769, November 13, 2009 ª2009 Elsevier Inc.logs, Mad and Yorkie, to interact in S2 Drosophila cells. Endog-
enous or transfected epitope-tagged Yorkie could be coimmu-
noprecipitated with wild-type Flag-Mad, but not with a linker
phosphorylation site mutant (Figures 6F and 6G). Conversely,
no interaction was detected between wild-type Flag-Mad and
a WW domain Yorkie mutant (Figure 6H). The loss of interaction
of Yorkie with the Mad linker mutant indicates that overexpres-
sion of wild-type Mad leads to linker hyperphosphorylation,
as seen with overexpression of mammalian Smads (Sapkota
et al., 2007). The lack of Mad phospholinker antibodies
precluded corroboration of this interpretation. Taken together
these results show that YAP interacts with Smad1 with the
same binding requirements and selectivity as Smurf1 and
that this interaction is evolutionarily conserved from flies to
mammals.
YAP Enhances Smad1 Function
Given that BMP has roles in mouse embryonic stem cell (mESC)
self-renewal and differentiation (Varga and Wrana, 2005), we
chose mESCs to analyze the impact of YAP on BMP-mediated
gene responses. Transcriptomic analysis of BMP-stimulated
mESCs identified a limited number of BMP-responsive genes
(Table S1). The top-scoring genes on this list belonged to the
Id family (Id3, Id1, and Id4; with Id2 also among the top-ten
targets), which had been previously identified as prominent
BMP targets in undifferentiated and differentiating mESC
cultures (Hollnagel et al., 1999; Ying et al., 2003a). ChIP showed
that YAP and Smad1/5 were bound to the BMP-responsive
region of Id1 and Id2when these genes were actively transcribed
in response to BMP (Figure 7A). To test the effect of YAP on
BMP-dependent gene responses, we depleted YAP from
mESCs by stable shRNA transduction, generating two indepen-
dent cell lines, which exhibited 80% YAP knockdown without
significantly altering Smad1/5 levels (Figures S8A and S8B).
The effect of BMP on the expression of Id1, Id2, and Id3 was
sensitive to depletion of YAP (Figure 7B).
BMP inhibits neural differentiation of mouse ES cells through
the induction of Id proteins (Ying et al., 2003a). Moreover, acti-
vated Smad1/5 is abundant in the subventricular zone of the
mouse telencephalon (Figure 1C), which is rich in neural stem
and progenitor cells (Alvarez-Buylla and Lim, 2004). When incu-
bated in Leukemia inhibitory factor (LIF)- and serum-free media
supplemented with N2/B27, mESCs commit to neural cell line-
ages as shown by the expression of the neuronal marker b-III
tubulin (Tubb3), and this effect is drastically inhibited by BMP
(Figure 7C) (Ying et al., 2003b). YAP depletion attenuated this
effect of BMP, as determined by quantitative real-time PCR
(qRT-PCR) analysis of Tubb3 mRNA levels (Figure 7C) and
immunofluorescence staining of the cells with anti-tubb3 anti-
bodies (Figures 7D and S8). Collectively, these results suggest
that BMP-induced linker phosphorylation of Smad1 serves to
recruit YAP to Id genes for enhanced transcription.
To further probe the significance of the Smad1-YAP interac-
tion, we investigated whether their Drosophila counterparts
Mad and Yorkie (Yki) cooperate to affect Drosophila biological
processes in vivo. In the wing imaginal disc, a gradient of the
BMP ortholog Dpp activates Mad to achieve induction of target
genes such as vestigial (vg) for correct patterning and growth
(Kim et al., 1997). Overexpression of Yorkie in wing imaginal
disc clones induced ectopic expression of the vgQE-lacZ
reporter (Figure 7E), which contains a previously described
Mad-binding element (Kim et al., 1997). Yorkie-induced ectopic
vgQE-lacZ expression is discontinuous with the endogenous
expression domain of the reporter and is detected near the AP
boundary, where the Dpp signal is at its highest. Thus, the ectopic
vgQE-lacZ expression reflects an intrinsic response of the cells to
high levels of Yorkie and Dpp at those positions, rather than being
a result of clone overproliferation. The fact that this ectopic
expression is only observed at positions with the highest level
of Dpp further suggests that the cooperation between Mad andYorkie might be important for achieving a maximum level of
Dpp signaling. Thus Mad and Yorkie parallel in Drosophila the
role established in the mammalian ES cell system for the
Smad1-YAP interaction and the induction of BMP target genes.
DISCUSSION
The present findings reveal a remarkable integration of Smad
regulatory functions by agonist-induced, CDK8/9-mediated
phosphorylation of the linker region and highlight this event as
an integral feature of the transcriptional action and turnover of
receptor-activated Smad proteins (Figure 7F).
Smad Linker Phosphorylation by CDK8/9 in Canonical
BMP and TGF-b Pathways
Agonist-induced linker phosphorylation of R-Smads is a general
feature of BMP and TGF-b pathways, occurring in all the respon-
sive cell types examined, shortly after Smad tail phosphorylation.
Our evidence identifies CDK8 and CDK9 as the kinases involved
and does not support a major role for MAPKs or cell-cycle-regu-
latory CDKs in this process. CDK8 and cyclinC are components
of the Mediator complex that couples enhancer-binding tran-
scriptional activators to RNAP II for transcription initiation (Malik
and Roeder, 2005). CDK9 and cyclinT1 constitute the P-TEFb
complex, which promotes transcriptional elongation (Bres et al.,
2008). CDK8 and CDK9 phosphorylate overlapping serine clus-
ters in the C-terminal domain of RNAP II (Phatnani and Greenleaf,
2006), a region which integrates regulatory inputs by binding
proteins involved in mRNA biogenesis (Phatnani and Greenleaf,
2006). Thus, CDK8 and CDK9 may provide coordinated regula-
tion of Smad transcriptional activators and RNAP II.
Precedent exists for the ability of CDK8 to phosphorylate
enhancer-binding transcription factors. The CDK8 ortholog
Srb10 in budding yeast phosphorylates Gcn4 marking this tran-
scriptional activator of amino acid biosynthesis for recognition
by the SCF(Cdc4) ubiquitin ligase (Chi et al., 2001). In mamma-
lian cells, CDK8 phosphorylates the ICD signal transduction
component of Notch, targeting it to the Fbw7/Sel10 ubiquitin
ligase (Fryer et al., 2004). However, whereas CDK8-mediated
phosphorylation inhibits Gcn4 and Notch activity, we show
here that phosphorylation of agonist-activated Smads by
CDK8/9 enables Smad-dependent transcription before trig-
gering Smad turnover.
One Structure, Two Binding Partners, and Two Opposite
Functions
Activated Smads undergo proteasome-mediated degradation
(Lo and Massague´, 1999) as well as phosphatase-mediated tail
dephosphorylation (Inman et al., 2002) to keep signal transduction
closely tied to receptor activation. We show that BMP-induced
Smad1-ALP generates binding sites for Smurf1, accomplishing
in the nucleus what MAPK-mediated phosphorylation of basal-
state Smad1 accomplishes in the cytoplasm (Sapkota et al.,
2007) (Figure 7F).Similarly, TGF-b-induced linker phosphorylation
of Smad2/3 provides a binding site for Nedd4L (Gao et al., 2009).
Our results also reveal a positive role for ALP in Smad-depen-
dent transcription. Smad proteins with phosphorylation-resis-
tant linker mutations are more stable as receptor-activatedCell 139, 757–769, November 13, 2009 ª2009 Elsevier Inc. 765
Figure 7. YAP Enhances BMP-Smad Responses in Different Biological Contexts
(A) Chromatin immunoprecipitation of BMP-stimulated mESCs using antibodies against YAP and Smad1/5. BMP-responsive regions of Id1 and Id2 and an unre-
sponsive control region of Id1 (control) were analyzed by qRT-PCR as in Figure 2D.
(B) Wild-type YAP-knockdown mESCs were stimulated with BMP4 for 1 hr. Total RNA was analyzed by qRT-PCR. Data show the mean ± SD of quadruplicates
and are representative of two independent experiments.
(C) Gene expression analysis of the neural differentiation marker b-III tubulin (Tubb3) in differentiating wild-type and YAP-knockdown mESCs. Cells were cultured
in N2B27 supplemented media in the presence or absence of BMP and harvested 5 days later, and total RNA was subjected to qRT-PCR analysis for Tubb3
expression as in (B).
(D) Confocal images of mESCs treated as in (C) and subjected to immunofluorescence staining with an anti-Tubb3 antibody (green) and DAPI counterstaining
(blue). Tubb3 staining detects neuronal differentiation.
(E) vgQE-lacZ expression (red) in Drosophila wing imaginal disc containing Yorkie-overexpressing clones (marked by GFP+). Confocal z stack through the wing
imaginal disc was projected into a single plane. Note that the ectopic vgQE-lacZ expression (asterisk) is discontinuous with the endogenous vgQE-lacZ expres-
sion domain (arrowhead) and only observed close to the anterior-posterior compartment boundary (arrow).
(F) The Smad signaling cycle. Receptor-bound BMP and TGF-b ligands induce C-tail phosphorylation of R-Smads, which then accumulate in the nucleus. Nuclear
R-Smads complexed with Smad4, bind to the regulatory elements of target genes and interact with other DNA-binding cofactors (shown as a gray box),
becoming linker-phosphorylated by CDK8/9 at some point during this process. This facilitates Smad1 binding to YAP, which is required for efficient transcription
of BMP target genes. Linker-phosphorylated Smad2/3 is thought to activate transcription of TGF-b target genes in a similar manner, but through as yet unknown
cofactors. After fulfilling their transcriptional role, Smads may be targeted by linker and tail phosphatases that reset them to their ground state or linker phospha-
tases only that may allow further Smad activity. Alternatively, Smads can be recognized in a phospholinker-dependent manner by ubiquitin ligases, such as
Smurf1 in the case of Smad1 and Nedd4L in the case of Smad2/3, resulting in their eventual degradation. The R-Smad linker regions can also be phosphorylated766 Cell 139, 757–769, November 13, 2009 ª2009 Elsevier Inc.
signal transducers than their wild-type counterparts, yet they are
transcriptionally less active. Indeed, mutation of Smad1 linker
phosphorylation sites (in a wild-type Smad5 background) does
not result in a straight BMP gain-of-function phenotype but
rather in an unforeseen gastric epithelial phenotype (Aubin
et al., 2004). Although the interpretation of this phenotype is
confounded by the contribution of MAPK signaling to linker
phosphorylation, it is consistent with the present evidence that
Smad1 linker phosphorylation plays an active role in BMP
signaling.
Focusing on Smad1 to define this dual role, we have found that
the phosphorylated linker sites, together with a neighboring PY
motif, are recognized also by the transcriptional coactivator
YAP. Smurf1 and YAP present closely related WW domains
with a similar selectivity toward linker-phosphorylated Smad1.
YAP is recruited with Smad1 to BMP responsive enhancers
and knockdown of YAP inhibits BMP-induced Id gene responses
in mouse embryonic stem cells. Both BMP and YAP act as
suppressors of neural differentiation in specific contexts (Cao
et al., 2008; Varga and Wrana, 2005). As we show here YAP
supports the ability of BMP to block neural lineage commitment
through the induction of Id family members (Ying et al., 2003a),
creating a link between YAP-dependent BMP transcriptional
output and ES cell fate determination.
Thus, a common structure fulfills two opposite functions—
Smad1 transcriptional action and turnover—by recruiting dif-
ferent proteins, YAP and Smurf1, at different stages of the signal
transduction cycle (Figure 7). The cyclic recruitment and con-
tinuous turnover of transcription factors on target enhancers
are required for the proper response of cells to developmental
and homeostatic cues. We propose that Smad activation by
TGF-b family agonists accomplishes this important requirement
through linker phosphorylation that triggers transcriptional
action and messenger turnover in one stroke.
A Link to the Hippo Pathway
Activation of the Hippo pathway by cell density cues triggers
a kinase cascade that culminates in the inactivation of YAP
(Yorkie in Drosophila), a transcriptional coactivator that acts
through interactions with enhancer-binding factors, including
TEAD/scalloped, Runx, p73, and others (Edgar, 2006; Pan,
2007; Zeng and Hong, 2008). Yorkie/YAP promotes cell prolifer-
ation and survival and organ growth, whereas the upstream
components of the inhibitory kinase cascade constrain organ
size and act as tumor suppressors (Dong et al., 2007; Overholt-
zer et al., 2006; Zhao et al., 2007). Elucidating the links between
the Hippo pathway and other signaling cascades is an important
open question (Edgar, 2006; Pan, 2007; Zeng and Hong, 2008).
Our evidence that YAP is recruited to BMP-activated Smad1
reveals a link between the BMP and the Hippo pathways. Both
these signaling cascades have the capacity to control organ
size and do so in a manner suggestive of interactions with other
patterned signals (Affolter and Basler, 2007; Martin-Castellanos
and Edgar, 2002). An example is the regulation of imaginal discgrowth by Dpp via cell competition, a process by which slow
proliferating cells are eliminated in favor of their higher-prolifer-
ating neighbors (Moreno et al., 2002). A genetic screen for nega-
tive regulators of Dpp signaling that protect cells from being
outcompeted identified upstream components of the Hippo
pathway (Tyler et al., 2007). Inactivation of these factors elevated
Dpp target gene expression, presumably by failing to inhibit
Yorkie, and allowed cells to outcompete their neighbors, sug-
gesting a functional convergence of the Hippo and BMP path-
ways that foreshadowed our findings.
Although ALP is a general event in Smad activation, YAP may
not be a universal partner of linker-phosphorylated Smad1.
Smad ALP likely plays a wider role potentially acting to recruit
coactivators other than YAP, depending on the cellular context
or the target gene. Also of interest is the identity of factors
that may play an analogous role in linker-phosphorylated
Smad2/3 in the TGF-b pathway. The linker phosphorylation sites
and PY motifs of Smad1 and Smad2/3 are conserved in the
otherwise divergent linker regions of the Drosophila orthologs
Mad/dSmad1 and Smox/dSmad2, respectively (Figure S1C).
Although the contribution of the MAPK pathway in linker phos-
phorylation precludes a clearcut genetic investigation of these
functions, they are probably conserved across metazoans.
A concerted search for Smad phospholinker interacting factors
would answer many of these questions and would fully elucidate
the role of the Smad linker region as a centerpiece in the function,
regulation, and connectivity of Smad transcription factors.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfections
HaCaT keratinocytes, HEK293T cells, SW480 colorectal adenocarcinoma
cells, and wild-type, Smad1 L/L, and Smad1 c/c MEFs were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) with 10% FBS. Mouse C2C12 cells
were maintained in DMEM with 20% FBS. Mv1Lu tetracycline-inducible cells
were cultured as described (Blain and Massague´, 2000). BxPC3 cells were
maintained in RPMI1640 media with 10% FBS. The SW480 and BxPC3
Smad4 stable cell lines were generated previously (He et al., 2006) and
HeLa-S3 cells stably expressing Flag-tagged Smad3 with shRNA-mediated
Nedd4L stable knockdown are described elsewhere (Gao et al., 2009). Mouse
embryonic stem cells E14Tg2a.IV were maintained in feeder-layer free LIF-
supplemented medium (Keller, 1995). Prior to total RNA extraction ES cells
were treated with BMP4 (25 ng/ml, R&D Systems) for 1 hr. Differentiation
assays were carried out as described (Ying et al., 2003b) in the presence or
absence of BMP2 (25 ng/ml, R&D Systems).
Prior to treatment with BMP2 (25 ng/ml, R&D systems), TGF-b1 (100 pM,
R&D Systems), or UV radiation (200 mJ/m2), cells were serum-starved for 16
hr. The chemical inhibitors U0126 (10 mM, Promega), SP600125 (10 mM, Cal-
biochem), SB203580 (10 mM, Calbiochem), MG132 (10 mM, Calbiochem),
LY294002 (100 mM, Calbiochem), Flavopiridol (0.3 mM, National Cancer Insti-
tute), Roscovitine (50 mM, Calbiochem), SU11248 (5 mM), CGP57380 (5 mM,
Sigma-Aldrich), TG003 (10 mM, Calbiochem), Ro318220 (5 mM, Calbiochem),
CHIR 99021 and CHIR 98014 (both 2 mM, Division of Signal Transduction
Therapy, School of Life Sciences, Dundee University), UCN01 (2 mM, Calbio-
chem), DRB (50 mM, Calbiochem), and Purvalanol A (2 mM, Calbiochem)
were added to cells 30 min prior to BMP2 or TGF-b1 addition. Transfections
of mammalian and Drosophila S2 cells and siRNA oligonucleotides were as
described (Sapkota et al., 2007; Wu et al., 2003; Knockaert et al., 2006).by MAPK pathway kinases in response to antagonists, such as FGF, EGF, or stress signals, which ultimately leads to Smad degradation. By providing a platform
for the regulation of the different and often opposing fates of the Smads, linker phosphorylation represents a focal point in the Smad signaling
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Nuclear and cytosolic fractionations were performed with a Nuclear and
Cytoplasmic Extraction Kit (Pierce) following the manufacturer’s instructions.
Immunohistochemistry and Immunofluorescence
Immunohistochemistry (IHC) and immunofluorescence (IF) of mouse embryo
tissue sections were processed at the Molecular Cytology Core Facility of
MSKCC using a Discovery XT processor (Ventana Medical Systems). Tissue
sections were blocked for 30 min in 10% normal goat serum, 2% BSA in
PBS, followed by avidin/biotin block (12 min for Smad1 and 16 min for
Smad2 antibodies). The 3 hr primary antibody incubation was followed by 1
hr incubation with biotinylated goat anti-rabbit IgG (ABC kit; Vector labs;
1:200 dilution). For IHC, detection was performed with the DAB detection kit
(Ventana Medical Systems) according to the manufacturer’s instructions. For
IF, detection was performed with Streptavidin-HRP D (Ventana Medical
Systems), followed by incubation with Tyramide-Alexa Fluor 488 (Invitrogen)
or Tyramide-Alexa Fluor 568 (Invitrogen). The double IF was carried out
sequentially.
For IF of Smad1 and Smad3 phosphotail and phopsho-linker in cell lines,
HaCaT cells were fixed in 4% paraformaldehyde and immunostained with
the indicated antibodies as described previously (Xu et al., 2002).
Drosophila Genetics
Flies of the genotype y w hs-Flp; vgQE-lacZ/+; Act > CD2 > Gal4, UAS-GFP/
UAS-Yorkie were heat shocked at 48–60 hr after egg deposition to induce
Yorkie-overexpressing clones in imaginal discs. UAS-Yorkie and vgQE-lacZ
were described in Huang et al. (2005) and (Kim et al., 1997), respectively.
Confocal images were collected on a Zeiss 510 microscope and processed
using the Zeiss LSM Image software.
Other Assays
Immunoprecipitations, western immunoblotting, and kinase assays were done
as previously described (Sapkota et al., 2007). Chromatin immunoprecipita-
tions were performed with a ChIP kit (Upstate Biotechnology Inc.) following
the manufacturer’s protocol with modifications and details described in the
Supplemental Experimental Procedures. CDK9/cyclinT and CDK8/cyclinC
complexes were purchased from Invitrogen and CDK7/cyclinH was a gift
from Dr. R.P. Fisher (MSKCC). Total RNA extraction, reverse transcription,
and qRT-PCR to detect gene transcript levels were performed as previously
described (Knockaert et al., 2006). Primers used in qRT-PCR analysis are
listed in Table S2. For microarray analysis, duplicate RNA samples were
extracted from E14Tg2a.IV cells treated with BMP2 for 1 hr and untreated
control cells. Array hybridization and data analysis were performed as previ-
ously described (Xi et al., 2008) using the MOE 430 2.0 mouse platform.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, eight
figures, and two tables and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)01312-9.
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